LaJolla Pharmaceutical Company ljpc.com


Public list: BIO 2016 (619) Pharma Startups (4732)

Founded in 1989, La Jolla Pharmaceutical Company is a biotechnology company leading the development and marketing of novel therapeutics for antibody-mediated autoimmune diseases, such as lupus and antibody-mediated thrombosis.

Founded in 1989, La Jolla Pharmaceutical Company is a biotechnology company leading the development and marketing of novel therapeutics for antibody-mediated autoimmune diseases, such as lupus and antibody-mediated thrombosis.

Company (IPO / Went public)

Phone: 858-452-6600

Fax:

4365 Executive Drive
Suite 300
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
LaJolla Pharmaceutical Company $290.6M Feb 6, 2006
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related LaJolla Pharmaceutical Company Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Alta PartnersVenture CapitalSan Francisco, California, United StatesUnattributed VC - III, Unattributed VC - II, Unattributed VC
Brookside CapitalPrivate EquityBoston, Massachusetts, United StatesUnattributed VC - IV
AWM Investment CompanyInvestment BankNew York, New York, United StatesUnattributed VC - V, Unattributed VC - IV, Unattributed VC - III, Unattributed VC - II, Unattributed VC
Alfred I. duPont Testamentary TrustUnattributed VC - IV
See all 32 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Modified pectins, compositions and methods related thereto May 06, 2013 May 13, 2014 Patent
Modified pectins, compositions and methods related thereto May 06, 2013 Feb 25, 2014 Patent
Methods of treating iron overload Sep 06, 2017 Application
Compositions and methods related to gentamicin Jan 27, 2017 Application
Methods of administering hepcidin Jan 06, 2017 Application
See all 9 patents